Loading people...
Darryl Dias is a practicing invasive cardiologist and an active angel investor at the Angel Physicians Fund based in Northern Kentucky. Following his initial medical education, he completed a post-doctoral research fellowship at the University of Pennsylvania and an invasive cardiology fellowship at the University of Kentucky. Dias subsequently joined the Ohio Heart and Vascular Center at The Christ Hospital in 2003, where he currently continues his clinical practice. Through the Angel Physicians Fund, established in 2020 alongside Manish Bhandari, he evaluates seed and Series A healthcare investments ranging from $100,000 to $5 million. His venture portfolio includes early-stage medical device, diagnostic, and health technology companies such as Foldax, S4 Medical, Elucid, and Moray Medical. Dias currently focuses on leveraging his medical background to identify and back emerging therapeutics, health services, and medical technology startups.
Darryl Dias stands out as a visionary angel investor, playing a pivotal role in the advancement of healthcare innovation through his association with the Angel Physicians Fund. As an Angel at this esteemed organization, Darryl Dias is at the forefront of identifying and supporting groundbreaking startups that promise to reshape the medical landscape. His commitment extends beyond mere capital; he brings a wealth of experience and a keen understanding of the healthcare sector to every investment, acting as a strategic partner for emerging companies.
His investment focus areas are sharply defined, primarily targeting early-stage ventures within healthcare, biotechnology, medical technology, and digital health. Darryl Dias is particularly interested in companies developing disruptive technologies that address unmet medical needs, improve clinical outcomes, or enhance healthcare delivery efficiency. This includes innovations in diagnostics, therapeutics, medical devices, health IT, telemedicine platforms, and AI-driven healthcare solutions. He seeks out founders with strong scientific foundations and clear pathways to market, believing in the power of physician-led innovation to drive meaningful change.
While specific details of Darryl Dias's career background are not publicly detailed, his role as an angel investor with the Angel Physicians Fund suggests a profound connection to the medical community and a history of success that enables his philanthropic investment activities. It is common for angels in this space to have backgrounds as successful physicians, healthcare executives, or serial entrepreneurs who have built and exited companies within the life sciences sector. This background likely provides him with invaluable insights into market dynamics, regulatory challenges, and the scientific rigor required for success in healthcare.
Though specific notable investments are not disclosed, Darryl Dias's involvement with the Angel Physicians Fund implies a portfolio of promising early-stage healthcare companies. The fund itself is dedicated to leveraging the collective expertise and capital of physicians to invest in and mentor innovative healthcare startups. Through this collaborative model, Darryl Dias contributes to a robust ecosystem that fosters the growth of companies poised to make significant impacts on global health. His dedication helps bridge the gap between groundbreaking research and commercial viability, ensuring that vital medical advancements receive the support they need to reach patients.
Darryl Dias is an angel investor associated with the Angel Physicians Fund, focusing on early-stage healthcare and life sciences companies.
Darryl Dias invests in early-stage healthcare, biotechnology, medical technology, and digital health companies, particularly those with disruptive technologies and strong scientific foundations.
Darryl Dias works as an Angel investor with the Angel Physicians Fund.
